Ultrahigh Energy Resolution Gamma-ray Spectrometers for Precision Measurements of Uranium Enrichment

Superconducting Gamma-ray detectors offer an order of magnitude higher energy resolution than conventional high-purity germanium detectors. This can significantly increase the precision of non-destructive isotope analysis for nuclear samples where line overlap affects the errors of the measurement. We have developed Gamma-detectors based on superconducting molybdenum-copper sensors and bulk tin absorbers for nuclear science and national security applications. They have, depending on design, an energy resolution between {approx}50 and {approx}150 eV FWHM at {approx}100 keV. Here we apply this detector technology to the measurement of uranium isotope ratios, and discuss the trade-offs between energy resolution and quantum efficiency involved in detector design

Compact RF resonator for cryogenic ion traps

We report on the investigation and implementation of a lumped-component, radio-frequency resonator used in a cryogenic vacuum environment to drive an ion trap. The resonator was required to achieve the voltages necessary to trap (about 100 V), while dissipating as little power as possible (< 250 mW). Ultimately a voltage gain of 100 was measured at 5.7 K. Single calcium ions were confined in a trap driven by this device, providing proof of successful resonator operation at low temperature.Comment: 6 pages, 4 figure

Operation of a planar-electrode ion-trap array with adjustable RF electrodes

One path to realizing systems of trapped atomic ions suitable for large-scale quantum computing and simulation is to create a two-dimensional (2D) array of ion traps. Interactions between nearest-neighbouring ions could then be turned on and off by tuning the ions’ relative positions and frequencies. We demonstrate and characterize the operation of a planar-electrode ion-trap array. By driving the trap with a network of phase-locked radio-frequency resonators which provide independently variable voltage amplitudes we vary the position and motional frequency of a Ca ion in two-dimensions within the trap array. Work on fabricating a miniaturised form of this 2D trap array is also described, which could ultimately provide a viable architecture for large-scale quantum simulations.published_or_final_versio

Fluor-schorl, a new member of the tourmaline supergroup, and new data on schorl from the cotype localities

Fluor-schorl, NaFe^(2+) _3Al_6Si_6O_(18)(BO_3)_3(OH)_3F, is a new mineral species of the tourmaline supergroup from alluvial tin deposits near Steinberg, Zschorlau, Erzgebirge (Saxonian Ore Mountains), Saxony, Germany, and from pegmatites near Grasstein (area from Mittewald to Sachsenklemme), Trentino, South Tyrol, Italy. Fluor-schorl was formed as a pneumatolytic phase and in high-temperature hydrothermal veins in granitic pegmatites. Crystals are black (pale brownish to pale greyish-bluish, if distance (r^2 = 0.93). This correlation indicates that Fe^(2+)-rich tourmalines from the investigated localities clearly tend to have a F-rich or F-dominant composition. A further strong positive correlation (r^2 = 0.82) exists between the refined F content and the Y–W (F,OH) distance, and the latter may be used to quickly estimate the F content

Variability in MRI vs. ultrasound measures of prostate volume and its impact on treatment recommendations for favorable-risk prostate cancer patients: a case series

Background: Prostate volume can affect whether patients qualify for brachytherapy (desired size ≥20 mL and ≤60 mL) and/or active surveillance (desired PSA density ≤0.15 for very low risk disease). This study examines variability in prostate volume measurements depending on imaging modality used (ultrasound versus MRI) and volume calculation technique (contouring versus ellipsoid) and quantifies the impact of this variability on treatment recommendations for men with favorable-risk prostate cancer. Methods: We examined 70 patients who presented consecutively for consideration of brachytherapy for favorable-risk prostate cancer who had volume estimates by three methods: contoured axial ultrasound slices, ultrasound ellipsoid (height × width × length × 0.523) calculation, and endorectal coil MRI (erMRI) ellipsoid calculation. Results: Average gland size by the contoured ultrasound, ellipsoid ultrasound, and erMRI methods were 33.99, 37.16, and 39.62 mLs, respectively. All pairwise comparisons between methods were statistically significant (all p < 0.015). Of the 66 patients who volumetrically qualified for brachytherapy on ellipsoid ultrasound measures, 22 (33.33%) did not qualify on ellipsoid erMRI or contoured ultrasound measures. 38 patients (54.28%) had PSA density ≤0.15 ng/dl as calculated using ellipsoid ultrasound volumes, compared to 34 (48.57%) and 38 patients (54.28%) using contoured ultrasound and ellipsoid erMRI volumes, respectively. Conclusions: The ultrasound ellipsoid and erMRI ellipsoid methods appeared to overestimate ultrasound contoured volume by an average of 9.34% and 16.57% respectively. 33.33% of those who qualified for brachytherapy based on ellipsoid ultrasound volume would be disqualified based on ultrasound contoured and/or erMRI ellipsoid volume. As treatment recommendations increasingly rely on estimates of prostate size, clinicians must consider method of volume estimation

Scintillators with potential to supersede lanthanum bromide

New scintillators for high-resolution gamma ray spectroscopy have been identified, grown and characterized. Our development efforts have focused on two classes of high light yield materials: Europium-doped alkaline earth halides and Cerium-doped garnets. Of the halide single crystals we have grown by the Bridgman method - SrI{sub 2}, CaI{sub 2}, SrBr{sub 2}, BaI{sub 2} and BaBr{sub 2} - SrI{sub 2} is the most promising. SrI{sub 2}(Eu) emits into the Eu{sup 2+} band, centered at 435 nm, with a decay time of 1.2 {micro}s and a light yield of up to 115,000 photons/MeV. It offers energy resolution better than 3% FWHM at 662 keV, and exhibits excellent light yield proportionality. Transparent ceramics fabrication allows production of Gadolinium- and Terbium-based garnets which are not growable by melt techniques due to phase instabilities. While scintillation light yields of Cerium-doped ceramic garnets are high, light yield non-proportionality and slow decay components appear to limit their prospects for high energy resolution. We are developing an understanding of the mechanisms underlying energy dependent scintillation light yield non-proportionality and how it affects energy resolution. We have also identified aspects of optical design that can be optimized to enhance energy resolution

Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource

INTRODUCTION: The Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab) is a multidisciplinary, collaborative framework for the investigation of familial breast cancer. Based in Australia, the primary aim of kConFab is to facilitate high-quality research by amassing a large and comprehensive resource of epidemiological and clinical data with biospecimens from individuals at high risk of breast and/or ovarian cancer, and from their close relatives. METHODS: Epidemiological, family history and lifestyle data, as well as biospecimens, are collected from multiple-case breast cancer families ascertained through family cancer clinics in Australia and New Zealand. We used the Tyrer-Cuzick algorithms to assess the prospective risk of breast cancer in women in the kConFab cohort who were unaffected with breast cancer at the time of enrolment in the study. RESULTS: Of kConFab's first 822 families, 518 families had multiple cases of female breast cancer alone, 239 had cases of female breast and ovarian cancer, 37 had cases of female and male breast cancer, and 14 had both ovarian cancer as well as male and female breast cancer. Data are currently held for 11,422 people and germline DNAs for 7,389. Among the 812 families with at least one germline sample collected, the mean number of germline DNA samples collected per family is nine. Of the 747 families that have undergone some form of mutation screening, 229 (31%) carry a pathogenic or splice-site mutation in BRCA1 or BRCA2. Germline DNAs and data are stored from 773 proven carriers of BRCA1 or BRCA1 mutations. kConFab's fresh tissue bank includes 253 specimens of breast or ovarian tissue â both normal and malignant â including 126 from carriers of BRCA1 or BRCA2 mutations. CONCLUSION: These kConFab resources are available to researchers anywhere in the world, who may apply to kConFab for biospecimens and data for use in ethically approved, peer-reviewed projects. A high calculated risk from the Tyrer-Cuzick algorithms correlated closely with the subsequent occurrence of breast cancer in BRCA1 and BRCA2 mutation positive families, but this was less evident in families in which no pathogenic BRCA1 or BRCA2 mutation has been detected.Graham J Mann, Heather Thorne, Rosemary L Balleine, Phyllis N Butow, Christine L Clarke, Edward Edkins, Gerda M Evans, Sian Fereday, Eric Haan, Michael Gattas, Graham G Giles, Jack Goldblatt, John L Hopper, Judy Kirk, Jennifer A Leary, Geoffrey Lindeman, Eveline Niedermayr, Kelly-Anne Phillips, Sandra Picken, Gulietta M Pupo, Christobel Saunders, Clare L Scott, Amanda B Spurdle, Graeme Suthers, Kathy Tucker and Georgia Chenevix-Trenc